Literature DB >> 17990297

SUMO4 and its role in type 1 diabetes pathogenesis.

Cong-Yi Wang1, Jin-Xiong She.   

Abstract

Susceptibility to type 1 diabetes (T1D) is determined by interactions of multiple genes with unknown environmental factors. Despite the characterization of over 20 susceptibility regions for T1D, identification of specific genes in these regions is still a formidable challenge. In 2004, we first reported the cloning of a novel, small ubiquitin-like modifier (SUMO) gene, SUMO4, in the IDDM5 interval on chromosome 6q25, and presented strong genetic and functional evidence suggesting that SUMO4 is a T1D susceptibility gene. Subsequent studies have consistently confirmed this association in multiple Asian populations despite controversial observations in Caucasians. In this review, we will update the genetic evidence supporting SUMO4 as a T1D susceptibility gene and discuss the possible explanations for the discrepant associations observed in Caucasians. We will then discuss the mechanisms through which SUMO4 contributes to the pathogenesis of T1D. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17990297     DOI: 10.1002/dmrr.797

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  27 in total

Review 1.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 2.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Association of SUMO4 Met55Val variation with increased insulin resistance in newly diagnosed type 2 diabetes in a Chinese population.

Authors:  Zhenzhong Ji; Zhe Dai; Yan Huang; Hedson Alves Martins; Yancheng Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

4.  Engineering pre-SUMO4 as efficient substrate of SENP2.

Authors:  Yan Liu; Chris A Kieslich; Dimitrios Morikis; Jiayu Liao
Journal:  Protein Eng Des Sel       Date:  2014-04       Impact factor: 1.650

5.  Biochemical characterization of the small ubiquitin-like modifiers of Chlamydomonas reinhardtii.

Authors:  Yung-Cheng Shin; Bang-Yu Liu; Jia-Yun Tsai; Jiunn-Tzong Wu; Li-Kwan Chang; Shih-Chung Chang
Journal:  Planta       Date:  2010-06-11       Impact factor: 4.116

6.  Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival.

Authors:  Paige Selvy Dunphy; Tian Luo; Jere W McBride
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

7.  Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes.

Authors:  R Podolsky; M V Prasad Linga-Reddy; J-X She
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

Review 8.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

Review 9.  SUMO--a post-translational modification with therapeutic potential?

Authors:  Chang-Hoon Woo; Jun-Ichi Abe
Journal:  Curr Opin Pharmacol       Date:  2010-01-14       Impact factor: 5.547

10.  Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes.

Authors:  Jing Chen; Ying Lu; Chul-Ho Lee; Renhua Li; Edward H Leiter; Clayton E Mathews
Journal:  Free Radic Biol Med       Date:  2008-07-31       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.